U.S., Jan. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07313072) titled 'Topical Use of 2% Tofacitinib for Nail Psoriasis: an Exploratory Clinical Study' on Dec. 09, 2025.
Brief Summary: To evaluate the efficacy and safety of topical 2% tofacitinib nail lacquer in nail psoriasis, using the NAPSI and DLQI scales before and after 26 weeks of treatment.
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Nail Psoriasis
Intervention:
DRUG: Topical 2% Tofacitinib
Each study participant will receive a bottle of nail lacquer containing 2% tofacitinib. Application will be the responsibility of the participant and must be performed once daily throughout the entire study period.
Recruitment ...